4//SEC Filing
FOSTER JAMES C 4
Accession 0001127602-24-002765
CIK 0001100682other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:59 PM ET
Size
13.8 KB
Accession
0001127602-24-002765
Insider Transaction Report
Form 4
FOSTER JAMES C
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2024-01-29$224.56/sh−12,710$2,854,158→ 215,117 total - Exercise/Conversion
Common Stock
2024-01-29$144.67/sh+17,436$2,522,466→ 227,827 total - Exercise/Conversion
Stock Options (Right to Buy)
2024-01-29−17,436→ 0 totalExercise: $144.67From: 2020-02-22Exp: 2024-02-22→ Common Stock (17,436 underlying)
Holdings
- 7,580(indirect: 2022 GRAT)
Common Stock
- 2,250(indirect: By Trust)
Common Stock
- 10,000(indirect: By Spouse)
Common Stock
- 20,000(indirect: 2023 GRAT)
Common Stock
- 750(indirect: By Trust)
Common Stock
- 0(indirect: 2021 GRAT)
Common Stock
- 340(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]On 11/20/2023, 3,420 shares were transferred from the 2022 GRAT account to Direct holdings.
- [F2]On 11/20/2023, 4,328 shares were transferred from the 2021 GRAT account to Direct holdings.
- [F3]The transaction was executed as a net exercise, in which no shares were purchased or sold in the open market.
Documents
Issuer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CIK 0001100682
Entity typeother
Related Parties
1- filerCIK 0001141722
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 4:59 PM ET
- Size
- 13.8 KB